ADMA Biologics Statistics
NASDAQ: ADMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.17-0.17 (-1.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ADMA Biologics by the numbers
ADMA Biologics has a market capitalization of $2.92 billion based on 221.85M shares outstanding. Its trailing P/E ratio is 17.1, and its forward P/E is 14.1. The stock trades 20.0% above its 50-day average and 23.8% above its 200-day average.
Average daily trading volume is 3.23M shares, or about $42.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADMA valuation vs. peer median
| Metric | ADMA | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.92B | $3.07B | -5% |
| Forward P/E | 14.1 | 61.1 | -77% |
| Avg. volume | 3.23M | 1.89M | +71% |
Peer median across 8 companies: DNLI, VCEL, IOVA, RLAY, TARS, BEAM, CRSP, BCRX.
Valuation
- Market cap
- $2.92B
- P/E (TTM)
- 17.10
- Forward P/E
- 14.06
- Price / sales (latest FY)
- 5.73
- EPS (TTM)
- $0.77
- Shares outstanding
- 221.85M
Price and trading
- Previous close
- 13.34
- Open
- 13.26
- Day range
- 13.13 – 13.47
- 52-week range
- 7.21 – 20.46
- 52-week change
- -23.34%
- Beta
- —
- Volume
- 2.45M
- Average volume
- 3.23M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.92B
- Pe
- 17.10
- Forward Pe
- 14.06
- Eps
- 0.77
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.46
- Week52 Low
- 7.21
- Avg Volume
- 3.23M
- Shares Outstanding
- 221.85M
- Ma50
- 10.97
- Ma200
- 10.64
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -35.62%
- Pct From52w Low
- 82.66%